Integra LifeSciences Holdings Corporation (IART)

IART Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	1,542	1,558	1,542	1,372	1,518
Revenue Growth (YoY)	-1.03%	0.99%	12.43%	-9.60%	3.06%
Cost of Revenue	656.84	587.36	597.81	520.83	564.68
Gross Profit	884.74	970.31	944.64	851.03	952.88
Selling, General & Admin	656.64	616.32	637.45	594.53	687.6
Research & Development	104.19	101.19	93.05	77.38	79.57
Other Operating Expenses	12.38	13.88	16.91	27.76	91.94
Operating Expenses	773.21	731.39	747.41	699.66	859.12
Operating Income	111.53	238.92	197.23	151.37	93.76
Interest Expense / Income	51.38	49.59	50.4	71.58	53.96
Other Expense / Income	-20.92	-24.57	-67.84	-13.73	-20.3
Pretax Income	81.07	213.89	214.68	93.52	60.1
Income Tax	13.33	33.34	45.6	-40.37	9.9
Net Income	67.74	180.55	169.08	133.89	50.2
Net Income Growth	-62.48%	6.79%	26.28%	166.71%	-17.43%
Shares Outstanding (Basic)	80	83	85	85	86
Shares Outstanding (Diluted)	80	84	85	85	86
Shares Change	-3.81%	-2.30%	0.30%	-1.46%	2.97%
EPS (Basic)	0.85	2.18	2.00	1.58	0.59
EPS (Diluted)	0.84	2.16	1.98	1.57	0.58
EPS Growth	-61.11%	9.09%	26.11%	170.69%	-19.44%
Free Cash Flow	73.09	233.27	264.41	168.6	161.93
Free Cash Flow Per Share	0.91	2.81	3.12	1.99	1.89
Gross Margin	57.39%	62.29%	61.24%	62.03%	62.79%
Operating Margin	7.23%	15.34%	12.79%	11.03%	6.18%
Profit Margin	4.39%	11.59%	10.96%	9.76%	3.31%
Free Cash Flow Margin	4.74%	14.98%	17.14%	12.29%	10.67%
Effective Tax Rate	16.44%	15.59%	21.24%	-43.17%	16.48%
EBITDA	258.15	384.6	388.74	284.09	228.58
EBITDA Margin	16.75%	24.69%	25.20%	20.71%	15.06%
Depreciation & Amortization	125.7	121.12	123.67	118.99	114.52
EBIT	132.45	263.49	265.07	165.1	114.06
EBIT Margin	8.59%	16.92%	17.19%	12.03%	7.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).